[{"address1": "7 Times Square", "address2": "Suite 2503", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 904243, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 505158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior Vice President of Clinical Development", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 466430, "exercisedValue": 0, "unexercisedValue": 55739}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.28, "open": 1.27, "dayLow": 1.261, "dayHigh": 1.33, "regularMarketPreviousClose": 1.28, "regularMarketOpen": 1.27, "regularMarketDayLow": 1.261, "regularMarketDayHigh": 1.33, "payoutRatio": 0.0, "beta": 2.54, "forwardPE": -3.0465114, "volume": 1141307, "regularMarketVolume": 1141307, "averageVolume": 2464490, "averageVolume10days": 1285660, "averageDailyVolume10Day": 1285660, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 119009176, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 1.84, "fiftyDayAverage": 1.1894, "twoHundredDayAverage": 1.1805, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 106124168, "profitMargins": 0.0, "floatShares": 90562342, "sharesOutstanding": 90846704, "sharesShort": 8176648, "sharesShortPriorMonth": 7806570, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.09, "heldPercentInsiders": 0.00133, "heldPercentInstitutions": 0.0682, "shortRatio": 9.17, "shortPercentOfFloat": 0.090100005, "impliedSharesOutstanding": 90846704, "bookValue": 0.128, "priceToBook": 10.234374, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -30881000, "trailingEps": -0.5, "forwardEps": -0.43, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": -0.14935064, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 1.31, "targetHighPrice": 7.5, "targetLowPrice": 4.0, "targetMeanPrice": 5.83333, "targetMedianPrice": 6.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 13886000, "totalCashPerShare": 0.153, "totalDebt": 1001000, "quickRatio": 1.46, "currentRatio": 1.717, "debtToEquity": 10.576, "returnOnAssets": -1.5356599, "returnOnEquity": -41.478836, "freeCashflow": -24253624, "operatingCashflow": -35402000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyDayAverageChange": 0.120599985, "fiftyDayAverageChangePercent": 0.10139565, "twoHundredDayAverageChange": 0.12949991, "twoHundredDayAverageChangePercent": 0.109699205, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 2.3437479, "regularMarketPrice": 1.31, "corporateActions": [], "postMarketTime": 1744934394, "regularMarketTime": 1744920003, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 2.29008, "postMarketPrice": 1.34, "postMarketChange": 0.0300001, "regularMarketChange": 0.029999971, "regularMarketDayRange": "1.261 - 1.33", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2464490, "fiftyTwoWeekLowChange": 0.53999996, "fiftyTwoWeekLowChangePercent": 0.70129865, "fiftyTwoWeekRange": "0.77 - 1.84", "fiftyTwoWeekHighChange": -0.5300001, "fiftyTwoWeekHighChangePercent": -0.28804353, "fiftyTwoWeekChangePercent": -14.935064, "dividendDate": 1573171200, "earningsTimestamp": 1742501101, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.5, "epsForward": -0.43, "epsCurrentYear": -0.42333, "priceEpsCurrentYear": -3.0945125, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]